Application 022081

Type
NDA
Sponsor
GILEAD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LETAIRISAMBRISENTANTABLET;ORAL5MGYesNo
002LETAIRISAMBRISENTANTABLET;ORAL10MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
61958-0801LetairisAMBRISENTANGilead Sciences, IncNDACurrent
61958-0801LetairisAMBRISENTANGilead Sciences, IncNDACurrent
61958-0801LetairisAMBRISENTANGilead Sciences, IncNDACurrent
61958-0802LetairisAMBRISENTANGilead Sciences, IncNDACurrent
61958-0802LetairisAMBRISENTANGilead Sciences, IncNDACurrent
61958-0802LetairisAMBRISENTANGilead Sciences, IncNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
81888SUPPL 2025-04-08
81831SUPPL 2025-04-07
79448SUPPL 2024-08-20
76409ORIG 2023-11-06
67748SUPPL2021-06-09
65715SUPPL2020-12-23
60998SUPPL2019-11-20
59843SUPPL2019-08-27
59842SUPPL2019-08-26
59841SUPPL2019-08-26
58173APPL2019-04-01
58154SUPPL2019-03-29
56659SUPPL2018-12-07
56614SUPPL2018-12-03
49890SUPPL2017-09-29
49073SUPPL2017-07-25
46218SUPPL2016-12-19
16915SUPPL2015-10-08
6848SUPPL2015-10-06
6847SUPPL2014-10-30
21933SUPPL2014-08-01
38205SUPPL2014-05-06
29220SUPPL2014-05-06
6846SUPPL2014-02-04
16914SUPPL2014-02-03
6845SUPPL2013-08-22
38203SUPPL2013-08-21
29219SUPPL2012-10-23
38204SUPPL2012-10-22
16913SUPPL2012-02-17
6841SUPPL2012-02-17
6844SUPPL2011-07-21
38202SUPPL2011-07-20
6843SUPPL2011-03-08
38201SUPPL2011-03-07
38200SUPPL2010-10-25
29218SUPPL2010-10-20
24016ORIG2010-09-01
6842SUPPL2010-08-26
29216SUPPL2009-11-24
23353ORIG2009-09-02
16911SUPPL2009-08-13
16912SUPPL2009-07-09
29217SUPPL2009-07-08
38199SUPPL2009-06-10
29215SUPPL2009-06-10
38198SUPPL2008-11-07
29214SUPPL2008-10-14
16910SUPPL2008-02-25
29213SUPPL2008-02-19
6840SUPPL2007-12-03
21932ORIG2007-08-21
6839ORIG2007-07-05
38197ORIG2007-06-27